Literature DB >> 18366345

Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis.

Emanuela Caci1, Antonella Caputo, Alexandre Hinzpeter, Nicole Arous, Pascale Fanen, Nitin Sonawane, A S Verkman, Roberto Ravazzolo, Olga Zegarra-Moran, Luis J V Galietta.   

Abstract

CFTR (cystic fibrosis transmembrane conductance regulator) is an epithelial Cl- channel inhibited with high affinity and selectivity by the thiazolidinone compound CFTR(inh)-172. In the present study, we provide evidence that CFTR(inh)-172 acts directly on the CFTR. We introduced mutations in amino acid residues of the sixth transmembrane helix of the CFTR protein, a domain that has an important role in the formation of the channel pore. Basic and hydrophilic amino acids at positions 334-352 were replaced with alanine residues and the sensitivity to CFTR(inh)-172 was assessed using functional assays. We found that an arginine-to-alanine change at position 347 reduced the inhibitory potency of CFTR(inh)-172 by 20-30-fold. Mutagenesis of Arg347 to other amino acids also decreased the inhibitory potency, with aspartate producing near total loss of CFTR(inh)-172 activity. The results of the present study provide evidence that CFTR(inh)-172 interacts directly with CFTR, and that Arg347 is important for the interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18366345     DOI: 10.1042/BJ20080029

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels.

Authors:  Shipeng Wei; Bryan C Roessler; Mert Icyuz; Sylvain Chauvet; Binli Tao; John L Hartman; Kevin L Kirk
Journal:  FASEB J       Date:  2015-11-25       Impact factor: 5.191

Review 2.  Chloride channel-targeted therapy for secretory diarrheas.

Authors:  Jay R Thiagarajah; A S Verkman
Journal:  Curr Opin Pharmacol       Date:  2013-08-27       Impact factor: 5.547

Review 3.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

4.  Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model.

Authors:  Lukmanee Tradtrantip; N D Sonawane; Wan Namkung; A S Verkman
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

5.  Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP.

Authors:  Yonjung Kim; Marc O Anderson; Jinhong Park; Min Goo Lee; Wan Namkung; A S Verkman
Journal:  Mol Pharmacol       Date:  2015-07-14       Impact factor: 4.436

6.  Stimulation of mucosal secretion by lubiprostone (SPI-0211) in guinea pig small intestine and colon.

Authors:  Guijun Fei; Yu-Zhong Wang; Sumei Liu; Hong-Zhen Hu; Guo-Du Wang; Mei-Hua Qu; Xi-Yu Wang; Yun Xia; Xiaohong Sun; Laura M Bohn; Helen J Cooke; Jackie D Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

7.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

8.  Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.

Authors:  Darren M Hutt; David Herman; Ana P C Rodrigues; Sabrina Noel; Joseph M Pilewski; Jeanne Matteson; Ben Hoch; Wendy Kellner; Jeffery W Kelly; Andre Schmidt; Philip J Thomas; Yoshihiro Matsumura; William R Skach; Martina Gentzsch; John R Riordan; Eric J Sorscher; Tsukasa Okiyoneda; John R Yates; Gergely L Lukacs; Raymond A Frizzell; Gerard Manning; Joel M Gottesfeld; William E Balch
Journal:  Nat Chem Biol       Date:  2009-12-06       Impact factor: 15.040

9.  Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling.

Authors:  Mairi J Hunter; Kate J Treharne; Alexandra K Winter; Diane M Cassidy; Stephen Land; Anil Mehta
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

10.  Mutations at the signature sequence of CFTR create a Cd(2+)-gated chloride channel.

Authors:  Xiaohui Wang; Silvia G Bompadre; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2009-01       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.